​

Lixte Biotechnology Ownership | Who Owns Lixte Biotechnology?

OverviewFinancialsChart

Lixte Biotechnology Ownership Summary

Lixte Biotechnology is owned by 1.49% institutional investors, and 98.51% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.51% of its assets in Lixte Biotechnology shares.

LIXT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockLixte Biotechnology1.49%-98.51%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20231-90.91%248,084-54.71%11376.60%--100.00%--100.00%
Mar 31, 202311-26.67%547,770-23.02%-162.63%5-16.67%3-
Dec 31, 20221515.38%711,5779.67%-296.02%6-3200.00%
Sep 30, 202213-7.14%648,856-25.66%-134.26%6-14.29%1-75.00%
Jun 30, 20221427.27%872,865-27.88%-69.51%775.00%4-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index11.58K0.51%-76.00
Vanguard Institutional Extnd Mkt Idx Tr5.21K0.23%-
Fidelity Series Total Market Index2.71K0.12%-
Fidelity Nasdaq Composite Index2.58K0.11%-
Spartan Extended Market Index Pool E295.000.01%76.00
NT Ext Equity Mkt Idx Fd - L215.000.01%-
Northern Trust Extended Eq Market Idx215.000.01%-
State St US Extended Mkt Indx NL Cl C190.000.01%-
SSgA U.S. Extended Market Index Class I190.000.01%-
SSgA U.S. Total Market Index Strategy78.000.00%23.00

Recent Insider Transactions

DateNameRoleActivityValue
Oct 02, 2023Bernards Rene-Buy$10.24K
Oct 03, 2023Bernards Rene-Buy$13.87K
Oct 03, 2023van der Baan Bastiaan Jeroen President and CEOBuy$28.00K
Oct 03, 2023Bernards Rene-Buy$13.87K
Oct 02, 2023Bernards Rene-Buy$10.24K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2--
2023 Q45-
2023 Q3--
2023 Q2--

LIXT Ownership FAQ

Who Owns Lixte Biotechnology?

Lixte Biotechnology shareholders are primarily institutional investors at 1.49%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Lixte Biotechnology's industry, Biotech Stocks , is 109.70%, which Lixte Biotechnology falls below.

Does Blackrock own Lixte Biotechnology?

BlackRock is not among the top 10 institutional shareholders of Lixte Biotechnology.

Who is the top mutual fund holder of Lixte Biotechnology shares?

Fidelity Extended Market Index is the top mutual fund holder of Lixte Biotechnology shares, with 0.51% of its total shares outstanding invested in 11.58K Lixte Biotechnology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools